Sees Q4 adjusted EBITDA $8M-$9M. CareDx (CDNA) reported preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2024.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener